The purpose of this study is to compare the safety and effectiveness of taking lamivudine
(3TC) plus zidovudine (ZDV) plus a protease inhibitor (PI) with taking the 3TC/ZDV
combination tablet (Combivir) plus a PI. This study also examines how well patients follow
the dosing schedules for these drugs.
Doctors believe that taking Combivir plus a PI may be as effective as taking 3TC plus ZDV
plus a PI.
Phase:
N/A
Details
Lead Sponsor:
Glaxo Wellcome
Treatments:
HIV Protease Inhibitors Lamivudine Lamivudine, zidovudine drug combination Protease Inhibitors Zidovudine